Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Matteo Ferro(European Institute of Oncology), Giuseppe Di Lorenzo(Saint Camillus International University of Health and Medical Sciences), Giuseppe Lucarelli(University of Bari Aldo Moro), Octavian Sabin Tătaru(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Francesco Lasorsa(University of Bari Aldo Moro), Carlo Buonerba(CTO Andrea Alesini), Daniela Terracciano(Federico II University Hospital), Francesco Porpiglia(University of Turin), Michele Marchioni(University of Chieti-Pescara), Gennaro Musi(University of Milan), Felice Crocetto(University of Naples Federico II), Gian Maria Busetto(Sapienza University of Rome), Antonio Verde(University of Naples Federico II), Cristian Fiori(Ospedale San Luigi Gonzaga), Guru Sonpavde(AdventHealth Orlando), Alessandro Antonelli(University of Verona), Alessandro Veccia(University of Verona), Luca Scafuri(CTO Andrea Alesini), Biagio Barone(Ospedale San Paolo), Francesco Del Giudice(Sapienza University of Rome), Giuseppe Carrieri(University of Foggia), Luigi Schips(University of Chieti-Pescara), Pasquale Dolce
Cited by 9
Related Papers
Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
|Journal of Clinical Oncology|2011|686
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
|The World Journal of Men s Health|2019|468
NIFEDIPINE VERSUS TAMSULOSIN FOR THE MANAGEMENT OF LOWER URETERAL STONES
|The Journal of Urology|2004|242